Kinnate Biopharma (KNTE) Earnings Date, Estimates & Call Transcripts → Top Project Outperforms BTC in 2023… (From Crypto 101 Media) (Ad) Free KNTE Stock Alerts $2.66 0.00 (0.00%) (As of 03/28/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueKNTE Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.KNTE Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Crypto Swap ProfitsGrab Your Free Bitcoin Today!And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.>> Register right here Kinnate Biopharma Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20244($0.41)($0.36)($0.39)Q2 20244($0.42)($0.28)($0.38)Q3 20244($0.43)($0.28)($0.35)Q4 20244($0.44)($0.17)($0.33)FY 202416($1.70)($1.09)($1.44) Get Kinnate Biopharma Earnings AlertsEnter your email address below to receive the latest news and earnings results for KNTE and its competitors with MarketBeat's FREE daily newsletter. KNTE Earnings Date and InformationKinnate Biopharma last issued its earnings data on March 28th, 2024. The reported ($0.44) earnings per share (EPS) for the quarter. Kinnate Biopharma has generated ($2.78) earnings per share over the last year (($2.78) diluted earnings per share). Earnings for Kinnate Biopharma are expected to grow in the coming year, from ($2.51) to ($1.25) per share. Kinnate Biopharma has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, April 3rd, 2024 based off prior year's report dates.Read More Kinnate Biopharma Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 4/3/2024Estimated)------- 11/9/2023Q3 2023($0.69)($0.65)+$0.04($0.65)--8/8/2023Q2 2023($0.76)($0.68)+$0.08($0.68)--5/11/2023Q1 2023($0.73)($0.73)-($0.73)--3/15/2023Q4 2022($0.70)($0.72)($0.02)($0.72)--11/10/2022Q3 2022($0.60)($0.70)($0.10)($0.70)--8/11/2022Q2 2022($0.65)($0.62)+$0.03($0.62)-- Get the Latest News and Ratings for KNTE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Kinnate Biopharma and its competitors with MarketBeat's FREE daily newsletter. 5/12/2022Q1 2022($0.62)($0.61)+$0.01($0.61)-- 3/28/2022Q4 2021($0.60)($0.60)-($0.60)--11/10/2021Q3 2021($0.53)($0.57)($0.04)($0.57)--8/15/2021Q2 2021($0.43)($0.49)($0.06)($0.49)-- 5/17/2021Q1 2021($0.37)($0.40)($0.03)($0.40)-- Kinnate Biopharma Earnings - Frequently Asked Questions When is Kinnate Biopharma's earnings date? Kinnate Biopharma has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, April 3rd, 2024 based off last year's report dates. Learn more on KNTE's earnings history. How much profit does Kinnate Biopharma generate each year? Kinnate Biopharma (NASDAQ:KNTE) has a recorded net income of -$116.27 million. KNTE has generated -$2.78 earnings per share over the last four quarters. What is Kinnate Biopharma's EPS forecast for next year? Kinnate Biopharma's earnings are expected to grow from ($2.51) per share to ($1.25) per share in the next year. More Earnings Resources from MarketBeat Related Companies: IMUX Earnings Results MCRB Earnings Results CLSD Earnings Results CTXR Earnings Results RNAC Earnings Results ACRV Earnings Results ANIX Earnings Results ORMP Earnings Results SCTL Earnings Results VTGN Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Lululemon Stock Implodes Post Earnings, Guidance Muted Applied Optoelectronics earnings dumper, pain now for gain later?Is Roku worth a second look after the earnings panic selloff?Dell Technologies breaks out ahead of earnings releaseNovavax’s dispute resolution and upcoming earnings callImpinj stock surges on strong earnings and guidanceAirbnb stock bulls just went all in before earnings This page (NASDAQ:KNTE) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersGrab Your Free Bitcoin Today!Crypto Swap ProfitsMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceTop Project Outperforms BTC in 2023…Crypto 101 MediaForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryFed launches fourth dollar overhaulStansberry ResearchBREAKING: New AI Breakthrough Could Change Healthcare ForeverBehind the MarketsThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kinnate Biopharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.